Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine for Pediatric Feeding Disorders
NCT06751290Phase 4Completed
- Sponsor
- University of Miami
- Start
- Dec 2024
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyproheptadine in feeding disorder (PFD), Avoidant/Restrictive Food Intake Disorder (ARFID), sponsored by University of Miami. Started Dec 2024; status: completed.
02
Drugs
cyproheptadine
03
Conditions
feeding disorder (PFD)Avoidant/Restrictive Food Intake Disorder (ARFID)
Beyond the preview
Go deeper on NCT06751290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06751290.